Financings Of The Fortnight Parses Federal Funding For Roche/Genentech Alzheimer’s Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financing activity by Arena, OncoMed, Egalet and Dynavax.
You may also be interested in...
Lorcaserin Makes It Past Panel On The Strength Of Effect In Some Patients
The Endocrinologic and Metabolic Drugs Advisory Committee votes 18-4, with one abstention, in favor of lorcaserin for long-term treatment of overweight and obese individuals.
GSK And HGS Face Off Over Buyout
Human Genome Sciences says the long-term blockbuster opportunity in Benlysta and the potential of its pipeline products are under-valued by GlaxoSmithKline’s takeover offer. Management at GSK, however, plays down any talk of increasing its bid.
The Biopharma A List: Taking The Pulse Of Newco Creation
On the new company creation front, using Series A financings as a proxy, start-ups have not escaped the challenging funding environment. Here we update trends in those first-time rounds for 2023.